NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

dennisdave,

Retail investors don’t typically look at what is going on behind the scenes but I do. I like the big picture and NWBO and UCLA amongst others have been working hard to change the big picture. The talk about biomarkers is important for all future trials but seldom gets a mention here. Those that know about this biomarker evidence being included in submissions know the importance of it’s affect on future trials using them. Those that don’t or know that most others don’t can state that future trials will take an inordinate amount of time when the reality is they will be shortened dramatically not only by the use of biomarker evidence but also because of treatment effect and “sameness” of very specific DC characteristics created by very specific activation/maturation. The time to patient use will also be shortened due to newer legislation that gets patients to approved treatments sooner in other indications. Once the broader market figures this out they will all want cheap $5-$10 shares that no longer exist. Right now the market sees nothing to be excited about because they are not generally aware of the significance of manufacturing preparedness. The bigs do but they have been kept on the sidelines by their investing guidelines and the price Linda requires for doing business or because they have been potentially shelved as partners due to any past history of being involved working against NWBO. Much to be revealed and a great many good surprises await for patients and longs. Best wishes.